
Gateway Biotechnology
With a decade of product development funded by initial investment from co-founders and subsequent awards from the National Institutes of Health and the Department of Defense, Gateway Biotechnology has been developing small molecule and gene therapy-based treatments with proven safety records to combat hearing disorders. Its innovative approach, grounded in a deep understanding of basic mechanisms underlying hearing loss, targets multiple cellular pathways with new product formulations that fine-tune drug delivery to the ear.